HealthDay: Is new clot-busting medication better treatment for stroke?

UC expert says encouraging early findings need further study

Researchers are studying if a new "clot-busting" drug might be safer than the current treatment for strokes caused by brain bleeds.

The drug, tenecteplase, is currently approved for treating heart attacks but has not received FDA approval as a stroke treatment. 

Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, told HealthDay the new drug is easier to administer and is less costly than current standard treatments. However, early results showing its effectiveness in patient case studies need to be replicated in formalized clinical trials.

Read the HealthDay article.

Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati